Last reviewed: February 2001 (Awaiting review)
For general information about Cancerbackup's Discussion topics please see the introductory page.
This statement explores some of the issues involved in the treatment of metastatic prostate cancer. The management of prostate cancer is the subject of much controversy and continued debate. This is partly due to difficulties in accurate staging of the disease and partly due to the lack of randomised trials. These controversies are not limited to the UK but are worldwide.
This statement focuses on the management of metastatic prostate cancer. This is usually defined as disease that is incurable as it has become metastatic. However, some authors would argue that locally advanced tumours should also be included.(1)
For information on the management of early and locally advanced disease, refer to Cancerbackup's Medical Advisory Committee statements on early and locally advanced prostate cancer.